Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Number of Procedure, Sales Volume & ASP by Product, Application & End-users The global cardiac arrhythmia monitoring devices market will witness a robust CAGR of 4.41%, valued at $24.01 billion in 2021, expected to appreciate and reach $35.41 billion by 2030, confirms Strategic Market Research. In 2021, North America held the highest industry share of 35.78%. Arrhythmia monitoring refers to the tests used by doctors to determine the kind and cause of abnormal cardiac rhythms. Arrhythmias are abnormal heartbeats categorized according to their heart location and pace or rhythm. According to National Health Service, in September 2021, Arrhythmias or cardiac rhythm issues affected over 2 million people in the UK. According to these figures, the demand for Holter monitoring equipment is expected to rise. An electrocardiogram (ECG) is a basic test that records the heart's electrical activity. Electrodes linked to your body signal to a machine, which prints a visual representation of the heart's activity. An ECG is often performed with portable ECG devices at a doctor's office. As per a research study by SMR, it was revealed that approximately 1.5 million to 3 million electrocardiograms are conducted worldwide each year, thus making it one of the most commonly practiced cardiovascular diagnostic processes & one of the most fundamental tools in clinical practices. Key Industry Drivers - Increasing Cardiovascular Diseases Prevalence, Impact of Covid 19 The main cause of mortality globally is cardiovascular disease (CVD). According to the WHO (World Health Organization), cardiovascular disease (CVD) is one of the leading causes of mortality worldwide, with over 30 million individuals experiencing a serious cardiac attack or stroke yearly. The majority of CVDs can be avoided through pre-monitoring and pre-diagnosis. Early detection can help prevent arrhythmias, which are disturbances in the heart's activity. As a result, demand for CRM devices and CM is rising, as these devices can assist save patients who are prone to cardiac arrest. The market for arrhythmia monitoring devices is expected to rise due to the growing cardiac problems related to COVID-19. According to a July 2020 study titled "COVID-19 and cardiovascular disease: from fundamental principles to clinical perspectives, "COVID-19 individuals with underlying cardiovascular comorbidities have a significant death rate. Furthermore, the rising prevalence of diseases like chronic conditions, thyroid problems, diabetes, asthma, and Bradycardia is driving the industry of devices like Ambulatory monitoring devices, remote heart monitoring devices, Loop memory monitors, Patch recorders, Ambulatory Arrhythmia Monitoring, Real-Time Continuous Cardiac Monitoring System, and Implantable Cardioverter-Defibrillators. An elaborated research study was conducted by SMR, where it was discovered that around 300 million people worldwide are presently suffering from asthma & it’s projected to surge by almost 50% each decade. The research study also revealed that nearly 200 Million people worldwide suffer from thyroid problems globally. Thyroid dysfunction due to the deficiency of iodine affects around 30% of the global population. The above factors will further augment and propel the overall growth of the cardiac arrhythmia monitoring devices market. Restraints - Cybersecurity Risks are a Major Concern. Healthcare practitioners and patients are concerned about cybersecurity vulnerabilities for medical devices, specifically cardiac implantable electronic devices (CIED). A survey conducted in 2019 reported that up to 750,000 Medtronic PLC cardiac devices have a major cybersecurity vulnerability which may allow an attacker to have advanced insider knowledge to damage the patient by modifying the programming on a high-tech implanted defibrillator. Opportunities - CIED-related Infection Prevention Measures The government is taking several major steps to reduce the risk of infections caused for the excessive usage of CIEDs/Cardiac Implantable Electronic Devices. Hence, they introduced a brand new medicine in the market known as Prophylactic antibiotics, which has been found to reduce the incidence rate of CIED infections to a great extent. As per a research study carried out by SMR, it was figured out that this initiative of the global governments was indeed fruitful as these antibiotics showed a clinical success rate of around 96%. Thus, the rise in usage of these antibiotics to reduce CIED infections is anticipated to cater to a heck of opportunities in the upcoming time and further augment the demand for Cardiac Arrhythmia Monitoring Devices. Due to the continuous rise of cardiovascular diseases, governments from all across the globe are making plans to invest a healthy amount of funding towards the technological developments of cardiac arrhythmia monitoring devices, which in turn can cater to a plethora of opportunities for the market in the upcoming period of time. The WHO has reported that CVDs are among the most prominent causes of fatalities worldwide. Around 17.9 Million people, or around 32% of the global population, died from CVDs in 2019. Cardiac Arrhythmia Monitoring Devices Market Analysis Of Different Segments Covered in the Report Based on the Product ECG devices Holter monitor Event Monitors (Cardiac Event Monitors, Symptoms Event Monitors, COM or Cardiac output monitoring MCT or Mobile cardiac telemetry Implantable loop recorders (ILRs) Highly Advanced ECG monitors Based on the Type Pacemakers Defibrillators Based on End-User Hospitals Clinics Cardiac centers Ambulatory surgery centers (ASCs) Others Based on Application Tachycardia Atrial Tachycardia Ventricular Tachycardia Regional Coverage Analysis North America The U.S. Canada Mexico Rest of North America Europe France Germany Spain U.K Italy Rest of Europe Asia Pacific China India Japan Australia Rest of APAC LAMEA Brazil Saudi Arabia South Africa Rest of LAMEA Product Analysis & Insights The holter monitor segment led the market with a revenue of around 2.93 billion in 2021. This can be primarily attributed to the rising prevalence of various diseases due to the surge in consumption of various kinds of unhealthy foods & irregular lifestyles, thus impacting cardiac health, which in turn results in different types of coronary artery blockages & arrests. SMR conducted a vital research study, where it was figured out that nearly 58 million people die each year due to cardiac blockages all across the world. The research also showed that more than 95% of the world’s population suffer from health problems & around 80% of the chronic or NCD diseases occur due to an irregular lifestyle led by the people, such as the lack of proper exercise & diet. Type Analysis & Insights The defibrillators held the most significant cardiac arrhythmia monitoring devices market share in 2020. This category is also expected to have the greatest CAGR over the projection period. This industry's expansion is driven by factors like technical improvements in defibrillators and increased CVD prevalence. According to the CDC (Centers for Disease Control and Prevention), 12.1 million Americans will develop atrial fibrillation (AFib) by 2030 because AFib is the most prevalent kind of cardiac arrhythmia detected in patients. End-User Analysis & Insights The hospitals held the maximum share in 2020. The expanding incidence of cardiovascular disease, the rising number of cardiac implant surgeries, and patient visits to the hospitals for the purpose of diagnosis are contributing to the expansion of this segment's size. A research study showed that there were around 49k or more hospitalizations in Minnesota, United States, which counted to an admission rate of around 732 hospitalizations/100k people. However, the research study also showed that the country with the highest number of patients suffering from CVD hospitalized in 2020 was China, followed by India, Russian Federation, the United States, & Indonesia. Regional Analysis & Insights The North America accounted for the maximum share. The rising incidence of Cardio Vascular Diseases, rising disposable income, rising healthcare spending, rising healthcare awareness, and the availability of technologically sophisticated gadgets in the area contribute to this market segment's majority share. According to the American Heart Association, approximately half of all individuals in the U.S. suffer from cardiovascular disease. CVD is poised to affect more than 130 million individuals, or 45.1 percent of the US population, by 2035. Cardiac Arrhythmia Monitoring Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 24.01 Billion The revenue forecast in 2030 USD 35.41 Billion Growth rate CAGR of approximately 4.41% The base year for estimation 2021 Unit USD Billion, CAGR (2020 - 2030) Segmentation By Product, By Type, By End-User, By Region By Product ECG devices, Implantable loop recorders (ILRs), Event Monitors, Mobile cardiac telemetry (MCT), COM or Cardiac output monitoring , and Highly Advanced ECG monitors. By Type Defibrillators, Pacemakers By End-User Hospitals, Clinics, Cardiac centers, Ambulatory surgery centers (ASCs), Others By Region North America, Asia Pacific, Europe, LAMEA Country Scope Canada, U.S, France, Germany, U.K., India, Japan, China, Brazil, Mexico, South Korea, U.A.E. etc. Company Usability Profiles Medtronic, Shenzhen Mindray Biomedical Electronics, Abbott Laboratories, BIOTRONIK, Koninklijke Philips, Boston Scientific, Hill-Rom Holdings, SCHILLER AG, BioTelemetry, BPL Medical Technologies, Asahi Kasei Corporation, Lepu Medical Technology, Shree Pacetronix, Nihon Kohden, OSYPKA, MicroPort Scientific Corp, GE Healthcare, BTL, Coala Life, Alivecor, Inc., Amiitalia, Bexen Cardio, ACS Diagnostics Narang Medical Ltd, MeTrax GmbH, Progetti Srl, RhythMedix. Cardiac Arrhythmia Monitoring Devices Market Competitive Landscape Overview The competitive landscape analysis provides key insights into the crucial competitors prevailing in the environment. The comparative analysis is conducted based on SWOT Analysis, overall revenue generation, company overview, company financials, industry initiatives, global presence, PESTLE Analysis, investment in R&D, production sites and facilities, production capacity, and potential, among others. Koninklijke Philips (Netherlands) BIOTRONIK(Germany) Abbott Laboratories (US) Boston Scientific Medtronic Shenzhen Mindray bio–Medical Electronics GE Healthcare MicroPort Scientific corp BioTelemetry BPL Medical Technologies SCHILLER AG Hill-Rom Holdings Asahi Kasei corp Nihon Kohden OSYPKA Shree pacetronix ACS Diagnostics Narang Medical Limited RhythMedix Progetti Srl Amiitalia Lepu Medical Technology Been Cardio Coala Life MeTrax GmbH (Deutschland) Alivecor, Inc. Most Recent Developments In January 2022, Biotricity's Biotres received 510(k) approval from the US FDA for its Cardiac Monitoring Device for arrhythmia monitoring and ECG. The Biotres Cardiac Monitoring Device is a wearable Holter patch that continuously records ECG data in three channels. This strategy has allowed the firm to diversify its cellular device product line in the United States. On June 2022, the company named Cardiologs started using the Holter recordings widely compared to the ECGs to detect more cases of atrial fibrillation. A detailed study on the Holter recordings was conducted by the French company, which showed that this algorithm could detect the absence or presence of AFib symptoms in the first twenty-four hours. On June 2022, Medicalgorithimics successfully got the FDA grant for launching its Qpatch wearable devices for accurately obtaining various electrocardiogram readings. Qpatch has an elnk screen that denotes the various readings of the interactions among the wearable devices. Also, the real-time readings provided by this device can easily be observed using quality control of the ECG signal that has been currently recorded. On June 2022, Apple launched its highly advanced software product WatchOS9 for accurately tracking various symptoms of AFib (atrial fibrillation) & monitoring medications. This product helped the company come at par with its arch competitors like Oura & Fitbit, and it also embraced Apple’s cardiac monitoring technology. On April 2022, Medtronic announced that it would release its highly efficient AI algorithm (AccuRhythm AI) for heart rate monitoring in the European region. This algorithm adequately applies the technology of AI to the cardiac rhythm event data that LiNQ II collects. This, in turn, provides highly accurate information to the surgeons; hence, they can treat the various abnormal cardiac rhythms without hesitation. In February 2021, RhythMedix announced that it would release its next-generation wearable cardiac telemetry monitor with integrated and built-in 4G cellular connectivity to diagnose arrhythmia. In December 2020, Coala Life began offering telecardiology services directly to patients. The device is a smartphone-powered, patch-free ECG monitor that delivers diagnostic quality both for patients and doctors and real-time detection of the most common type of cardiac arrhythmias. In October 2020, LIVMOR reported that the US FDA approved the LIVMOR Halo atrial fibrillation detection system, which uses continuous heart rate monitoring to diagnose atrial flutter precisely. Frequently Asked Question About This Report Key players in global market? The key market players include Boston Scientific, Abbott Laboratories, BIOTRONIK, Koninklijke Philips, Asahi Kasei Corporation, GE Healthcare, MicroPort Scientific Corporation, Nihon Kohden , BioTelemetry, BPL Medical Technologies, Shenzhen Mindray Bio-Medical Electronics , Medtronic, Lepu Medical Technology, ACS Diagnostics, Shree Pacetronix , OSYPKA , BTL, Coala Life, RhythMedix, Alivecor, Inc., Amiitalia, Bexen Cardio, Hill-Rom Holdings , Narang Medical Limited, MeTrax GmbH , SCHILLER AG , Progetti Srl, etc. Which region held the largest share in market? In the Regions segment, North America successfully held the highest proportion of share. The rising incidence of CVD, rising healthcare spending, rising disposable income, rising awareness of healthcare, & the wider availability of the high tech sophisticated gadgets in the area contribute to this market segments substantial share. What are the cardiac arrhythmia monitoring devices market growth? The global cardiac arrhythmia monitoring devices market is expected to grow at a compound annual growth rate (CAGR) of 4.41 % from 2021 to 2030 to reach USD 35.41 Billion by 2030. How big is the cardiac arrhythmia monitoring devices market? The global cardiac arrhythmia monitoring devices market size was $ 24.01 Bn in 2021 and is predicted to reach $ 35.41 Bn by 2030, with a CAGR of 4.41 %. Which region has the highest compounded annual growth rate in market? In the Regions segment, North America has the highest growth rate. Sources https://www.nhs.uk/conditions/arrhythmia/ https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) https://pubmed.ncbi.nlm.nih.gov/32690910/ https://www.cdc.gov/heartdisease/atrial_fibrillation.htm https://www.heart.org/en/news/2019/01/31/cardiovascular-diseases-affect-nearly-half-of-american-adults-statistics-show 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Cardiac Arrhythmia Monitoring Devices Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Cardiac Arrhythmia Monitoring Devices Market 4.2.1 market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 market, By Product, 2021 - 2030 (USD Million) 4.5 By Application Business Analysis 4.5.1 market, By Application, 2021 - 2030 (USD Million) 4.6 Type Business Analysis 4.6.1 market, By Type, 2021 - 2030 (USD Million) 4.7 End-User Business Analysis 4.7.1 market, By End-User, 2021 - 2030 (USD Million) 4.8 Value Chain Analysis 4.9 Market Variable Analysis 4.9.1 Market Drivers Analysis 4.9.2 Market Restraints Analysis 4.10 Business Environment Analysis Tool 4.10.1 market PEST analysis 4.10.2 market Porter’s analysis 4.11 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. End-User Analysis 5.11.1. Trends in End-User (2014-2020) 5.11.2. Trends in End-User (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. ECG devices 7.3.1. ECG devices market, 2021 - 2030 (USD Million) 7.4. Event Monitors 7.4.1. Event Monitors market, 2021 - 2030 (USD Million) 7.5. Implantable loop recorders (ILRs) 7.5.1. Implantable loop recorders (ILRs) market, 2021 - 2030 (USD Million) 7.6. Cardiac output monitoring (COM) 7.6.1. Cardiac output monitoring (COM) market, 2021 - 2030 (USD Million) 7.7. Mobile cardiac telemetry (MCT) 7.7.1. Mobile cardiac telemetry (MCT) market, 2021 - 2030 (USD Million) 7.8. Smart ECG monitors 7.8.1. Smart ECG monitors market, 2021 - 2030 (USD Million) 7.9. Holter Monitor 7.9.1. Holter Monitor market, 2021 - 2030 (USD Million) 7.10. Implantable Cardiac Monitor 7.10.1. Implantable Cardiac Monitor market, 2021 - 2030 (USD Million) 8. Market: By Application Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Tachycardia 8.3.1. Tachycardia Market, 2021 - 2030 (USD Million) 8.3.1.1 Atrial Tachycardia Market, 2021 - 2030 (USD Million) 8.3.1.2 Ventricular Tachycardia Market, 2021 - 2030 (USD Million) 8.4. Bradycardia 8.4.1. Bradycardia market, 2021 - 2030 (USD Million) 8.5. Premature Contraction 8.5.1. Premature Contraction market, 2021 - 2030 (USD Million) 8.6. Others 8.6.1. Others market, 2021 - 2030 (USD Million) 9. Market: By Type Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Defibrillators 9.3.1. Defibrillatorsmarket, 2021 - 2030 (USD Million) 9.4. Pacemakers 9.4.1. Pacemakers market, 2021 - 2030 (USD Million) 10. Market: By End-User Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Hospitals 10.3.1. Hospitals market, 2021 - 2030 (USD Million) 10.4. Clinics 10.4.1. Clinics market, 2021 - 2030 (USD Million) 10.5. Cardiac centres 10.5.1. Cardiac centres Market, 2021 - 2030 (USD Million) 10.6. Ambulatory surgery centres (ASCs) 10.6.1. Ambulatory surgery centres (ASCs) Market, 2021 - 2030 (USD Million) 10.7. Others 10.7.1. Others Market, 2021 - 2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North America market, By Product, 2021 - 2030 (USD Million) 11.1.2. North America market, By Application, 2021 - 2030 (USD Million) 11.1.3. North America market, by End-User, 2021 - 2030 (USD Million) 11.1.4. North America market, by Country, 2021 - 2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. market, By Product, 2021 - 2030 (USD Million) 11.1.4.1.2. U.S. market, By Application, 2021 - 2030 (USD Million) 11.1.4.1.3. U.S. market, by End-User, 2021 - 2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada market, By Product, 2021 - 2030 (USD Million) 11.1.4.2.2. Canada market, By Application, 2021 - 2030 (USD Million) 11.1.4.2.3. Canada market, by End-User, 2021 - 2030 (USD Million) 11.2. Europe 11.2.1. Europe market, By Product, 2021 - 2030 (USD Million) 11.2.2. Europe market, By Application, 2021 - 2030 (USD Million) 11.2.3. Europe market, by End-User, 2021 - 2030 (USD Million) 11.2.4. Europe market, by country, 2021 - 2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. market, By Product, 2021 - 2030 (USD Million) 11.2.4.1.2. U.K. market, By Application, 2021 - 2030 (USD Million) 11.2.4.1.3. U.K. market, by End-User, 2021 - 2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany market, By Product, 2021 - 2030 (USD Million) 11.2.4.2.2. Germany market, By Application, 2021 - 2030 (USD Million) 11.2.4.2.3. Germany market, by End-User, 2021 - 2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France market, By Product, 2021 - 2030 (USD Million) 11.2.4.3.2. France market, By Application, 2021 - 2030 (USD Million) 11.2.4.3.3. France market, by End-User, 2021 - 2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe market, By Product, 2021 - 2030 (USD Million) 11.2.4.4.2. Rest of Europe market, By Application, 2021 - 2030 (USD Million) 11.2.4.4.3. Rest of Europe market, by End-User, 2021 - 2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific market, By Product, 2021 - 2030 (USD Million) 11.3.2. Asia Pacific market, By Application, 2021 - 2030 (USD Million) 11.3.3. Asia Pacific market, by End-User, 2021 - 2030 (USD Million) 11.3.4. Asia Pacific market, by country, 2021 - 2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China market, By Product, 2021 - 2030 (USD Million) 11.3.4.1.2. China market, By Application, 2021 - 2030 (USD Million) 11.3.4.1.3. China market, by End-User, 2021 - 2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India market, By Product, 2021 - 2030 (USD Million) 11.3.4.2.2. India market, By Application, 2021 - 2030 (USD Million) 11.3.4.2.3. India market, by End-User, 2021 - 2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan market, By Product, 2021 - 2030 (USD Million) 11.3.4.3.2. Japan market, By Application, 2021 - 2030 (USD Million) 11.3.4.3.3. Japan market, by End-User, 2021 - 2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea market, By Product, 2021 - 2030 (USD Million) 11.3.4.4.2. South Korea market, By Application, 2021 - 2030 (USD Million) 11.3.4.4.3. South Korea market, by End-User, 2021 - 2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC market, By Product, 2021 - 2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC market, By Application, 2021 - 2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC market, by End-User, 2021 - 2030 (USD Million) 11.4. Latin America 11.4.1. Latin America market, By Product, 2021 - 2030 (USD Million) 11.4.2. Latin America market, By Application, 2021 - 2030 (USD Million) 11.4.3. Latin America market, by End-User, 2021 - 2030 (USD Million) 11.4.4. Latin America market, by country, 2021 - 2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil market, By Product, 2021 - 2030 (USD Million) 11.4.4.1.2. Brazil market, By Application, 2021 - 2030 (USD Million) 11.4.4.1.3. Brazil market, by End-User, 2021 - 2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico market, By Product, 2021 - 2030 (USD Million) 11.4.4.2.2. Mexico market, By Application, 2021 - 2030 (USD Million) 11.4.4.2.3. Mexico market, by End-User, 2021 - 2030 (USD Million) 11.4.4.3. Rest of Latin America 11.4.4.3.1. Rest of the Latin America market, By Product, 2021 - 2030 (USD Million) 11.4.4.3.2. Rest of the Latin America market, By Application, 2021 - 2030 (USD Million) 11.4.4.3.3. Rest of the Latin America market, by End-User, 2021 - 2030 (USD Million) 11.5. MEA 11.5.1. MEA market, By Product, 2021 - 2030 (USD Million) 11.5.2. MEA market, By Application, 2021 - 2030 (USD Million) 11.5.3. MEA market, by End-User, 2021 - 2030 (USD Million) 11.5.4. MEA market, by region, 2021 - 2030 (USD Million) 12. Competitive Landscape 12.1 MEDTRONIC (IRELAND) 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Solutions Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Boston Scientific (US) 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Solutions Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Abbott Laboratories (US) 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Solutions Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. GE Healthcare (US) 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Solutions Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. BIOTRONIK (Germany) 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Solutions Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Koninklijke Philips (Netherlands) 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Solutions Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. ASAHI KASEI CORPORATION (JAPAN) 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Solutions Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. MICROPORT SCIENTIFIC CORPORATION (CHINA) 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Solutions Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Hill-Rom Holdings (US) 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Solutions Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. Nihon Kohden (Japan) 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Solutions Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. SCHILLER AG (Switzerland) 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Solutions Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. BioTelemetry (US) 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Solutions Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. BPL Medical Technologies (India) 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Solutions Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.14. ACS Diagnostics (US) 12.14.1. Company overview 12.14.2. Financial performance 12.14.3. Solutions Portfolio Analysis 12.14.4. Business Strategy & Recent Development 12.15. Shenzhen Mindray Bio-Medical Electronics (China) 12.15.1. Company overview 12.15.2. Financial performance 12.15.3. Solutions Portfolio Analysis 12.15.4. Business Strategy & Recent Development 12.16. Lepu Medical Technology (China) 12.16.1. Company overview 12.16.2. Financial performance 12.16.3. Solutions Portfolio Analysis 12.16.4. Business Strategy & Recent Development 12.17. Shree Pacetronix (India) 12.17.1. Company overview 12.17.2. Financial performance 12.17.3. Solutions Portfolio Analysis 12.17.4. Business Strategy & Recent Development 12.18. OSYPKA (Germany) 12.18.1. Company overview 12.18.2. Financial performance 12.18.3. Solutions Portfolio Analysis 12.18.4. Business Strategy & Recent Development 12.19. BTL (US) 12.19.1. Company overview 12.19.2. Financial performance 12.19.3. Solutions Portfolio Analysis 12.19.4. Business Strategy & Recent Development 12.20. Coala Life 12.20.1. Company overview 12.20.2. Financial performance 12.20.3. Solutions Portfolio Analysis 12.20.4. Business Strategy & Recent Development 12.21. RhythMedix 12.21.1. Company overview 12.21.2. Financial performance 12.21.3. Solutions Portfolio Analysis 12.21.4. Business Strategy & Recent Development 12.22. Alivecor, Inc. (US) 12.22.1. Company overview 12.22.2. Financial performance 12.22.3. Solutions Portfolio Analysis 12.22.4. Business Strategy & Recent Development 12.23. Amiitalia (Italy) 12.23.1. Company overview 12.23.2. Financial performance 12.23.3. Solutions Portfolio Analysis 12.23.4. Business Strategy & Recent Development 12.24. Been Cardio (Spain) 12.24.1. Company overview 12.24.2. Financial performance 12.24.3. Solutions Portfolio Analysis 12.24.4. Business Strategy & Recent Development 12.25. Narang Medical Limited (India) 12.25.1. Company overview 12.25.2. Financial performance 12.25.3. Solutions Portfolio Analysis 12.25.4. Business Strategy & Recent Development 12.26. MeTrax GmbH (Germany) 12.26.1. Company overview 12.26.2. Financial performance 12.26.3. Solutions Portfolio Analysis 12.26.4. Business Strategy & Recent Development List of Tables (92 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR ECG devices, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Event Monitors, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Implantable loop recorders (ILRs), BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Cardiac output monitoring (COM), BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Mobile cardiac telemetry (MCT), BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Smart ECG monitors, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Holter Monitor, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Implantable Cardiac Monitor, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET, By Application, 2021-2030 (USD Million) TABLE 11. MARKET FOR Tachycardia, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Bradycardia, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Premature Contraction, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 16. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Clinics, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Cardiac centres, BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET FOR Ambulatory surgery centres (ASCs), BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET, By Type, 2021-2030 (USD Million) TABLE 22. MARKET FOR Defibrillators, BY REGION, 2021-2030 (USD Million) TABLE 23. MARKET FOR Pacemakers, BY REGION, 2021-2030 (USD Million) TABLE 24. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 27. NORTH AMERICA MARKET, By Application, 2021-2030 (USD Million) TABLE 28. NORTH AMERICA MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 29. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 30. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 31. EUROPE MARKET, By Application, 2021-2030 (USD Million) TABLE 32. EUROPE MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 34. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 35. ASIA-PACIFIC MARKET, By Application, 2021-2030 (USD Million) TABLE 36. ASIA-PACIFIC MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 37. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 38. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 39. LAMEA MARKET, By Type, 2021-2030 (USD Million) TABLE 40. LAMEA MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 41. MEDTRONIC (IRELAND): COMPANY SNAPSHOT TABLE 42. MEDTRONIC (IRELAND): OPERATING SEGMENTS TABLE 43. Boston Scientific (US): COMPANY SNAPSHOT TABLE 44. Boston Scientific (US): OPERATING SEGMENTS TABLE 45. Abbott Laboratories (US): COMPANY SNAPSHOT TABLE 46. Abbott Laboratories (US): OPERATING SEGMENTS TABLE 47. GE Healthcare (US): COMPANY SNAPSHOT TABLE 48. GE Healthcare (US): OPERATING SEGMENTS TABLE 49. BIOTRONIK (Germany): COMPANY SNAPSHOT TABLE 50. BIOTRONIK (Germany): OPERATING SEGMENTS TABLE 51. Koninklijke Philips (Netherlands): COMPANY SNAPSHOT TABLE 52. Koninklijke Philips (Netherlands): OPERATING SEGMENTS TABLE 53. ASAHI KASEI CORPORATION (JAPAN): COMPANY SNAPSHOT TABLE 54. ASAHI KASEI CORPORATION (JAPAN): OPERATING SEGMENTS TABLE 55. MICROPORT SCIENTIFIC CORPORATION (CHINA): COMPANY SNAPSHOT TABLE 56. MICROPORT SCIENTIFIC CORPORATION (CHINA): OPERATING SEGMENTS TABLE 57. Hill-Rom Holdings (US): COMPANY SNAPSHOT TABLE 58. Hill-Rom Holdings (US): OPERATING SEGMENTS TABLE 59. Nihon Kohden (Japan): COMPANY SNAPSHOT TABLE 60. Nihon Kohden (Japan): OPERATING SEGMENTS TABLE 61. SCHILLER AG (Switzerland): COMPANY SNAPSHOT TABLE 62. SCHILLER AG (Switzerland): OPERATING SEGMENTS TABLE 63. BioTelemetry (US): COMPANY SNAPSHOT TABLE 64. BioTelemetry (US): OPERATING SEGMENTS TABLE 65. BPL Medical Technologies (India): COMPANY SNAPSHOT TABLE 66. BPL Medical Technologies (India): OPERATING SEGMENTS TABLE 67. ACS Diagnostics (US): COMPANY SNAPSHOT TABLE 68. ACS Diagnostics (US): OPERATING SEGMENTS TABLE 69. Shenzhen Mindray Bio-Medical Electronics (China): COMPANY SNAPSHOT TABLE 70. Shenzhen Mindray Bio-Medical Electronics (China): OPERATING SEGMENTS TABLE 71. Lepu Medical Technology (China): COMPANY SNAPSHOT TABLE 72. Lepu Medical Technology (China): OPERATING SEGMENTS TABLE 73. Shree Pacetronix (India): COMPANY SNAPSHOT TABLE 74. Shree Pacetronix (India): OPERATING SEGMENTS TABLE 75. OSYPKA (Germany): COMPANY SNAPSHOT TABLE 76. OSYPKA (Germany): OPERATING SEGMENTS TABLE 77. BTL (US): COMPANY SNAPSHOT TABLE 78. BTL (US): OPERATING SEGMENTS TABLE 79. Coala Life: COMPANY SNAPSHOT TABLE 80. Coala Life: OPERATING SEGMENTS TABLE 81. RhythMedix: COMPANY SNAPSHOT TABLE 82. RhythMedix: OPERATING SEGMENTS TABLE 83. Alivecor, Inc. (US): COMPANY SNAPSHOT TABLE 84. Alivecor, Inc. (US): OPERATING SEGMENTS TABLE 85. Amiitalia (Italy): COMPANY SNAPSHOT TABLE 86. Amiitalia (Italy): OPERATING SEGMENTS TABLE 87. Been Cardio (Spain): COMPANY SNAPSHOT TABLE 88. Been Cardio (Spain): OPERATING SEGMENTS TABLE 89. Narang Medical Limited (India): COMPANY SNAPSHOT TABLE 90. Narang Medical Limited (India): OPERATING SEGMENTS TABLE 91. MeTrax GmbH (Germany): COMPANY SNAPSHOT TABLE 92. MeTrax GmbH (Germany): OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 26 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Cardiac Arrhythmia Monitoring Devices, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Cardiac Arrhythmia Monitoring Devices, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Application, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By End-User, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Type, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 ECG devices to Witness Higher CAGR in the Market for Product Segment during the Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in Market for End-user Segment during Forecast Period. Figure 18 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview